Sunscreen Innovation Act Starts Clock Ticking On FDA Review Of TEAs

Congress passes legislation to streamline FDA’s process for reviewing UV filter TEA submissions. The bill’s passing during Congress’ lame duck session reflects not only bipartisan support, but also lobbying by the personal-care product industry and consumer-health advocates to impose deadlines on FDA for long-sought changes to the OTC drug sunscreen monograph.

Congress passes the Sunscreen Innovation Act with hard deadlines for FDA’s review of time and extent applications for sunscreen ingredients and an expedited pathway for reviews of other OTC ingredient TEAs.

On Nov. 13, the House passed by unanimous consent the Senate version of the legislation, S

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight